A spotlight on the Pharmalys Regulatory Affairs Unit

Jul 15, 2025 | Quality & Business Excellence

As clinical research expands rapidly across the African continent, the demand for strategic and locally grounded regulatory support is becoming more critical than ever. From clinical trial start-up to post-marketing activities, effective regulatory oversight is key to ensuring timely access to safe, effective, and high-quality health products. Recognising and anticipating this evolution, Pharmalys pays tribute to its dedicated Regulatory Affairs and Study Start-up Unit (RAS Unit), a team committed to supporting research and development with precision, regional expertise, and unwavering integrity.

In an increasingly complex regulatory environment shaped by evolving ethical standards, scientific advancements, and national requirements, the Pharmalys RAS Unit plays a pivotal role. The team supports the successful launch and conduct of clinical trials, ensures compliance across all phases of the healthcare product lifecycle, and helps safeguard the rights and well-being of research participants, all while enabling sponsors and partners to navigate Africa’s diverse regulatory landscapes with confidence.

Regulatory Affairs Management at Pharmalys

Combining deep scientific expertise with a comprehensive understanding of local, regional, and international regulatory frameworks, the RAS Unit supports every stage of the clinical development process. From early phase trials through to post-marketing surveillance, the team works with precision, responsiveness, and regional insight to deliver robust regulatory solutions tailored to each project’s unique needs.

Key services include:

  • Developing regulatory strategies tailored to local and global requirements
  • Managing overall regulatory activities and projects
  • Preparing and submitting Clinical Trial Applications (CTAs)
  • Liaising with Ethics Committees and National Regulatory Authorities
  • Reviewing Informed Consent Forms and Protocols for compliance
  • Ensuring continuous regulatory compliance throughout project life cycles
  • Preparing amendments, reports, and ensuring inspection readiness
  • Mapping regulatory intelligence and requirements
  • Supporting the establishment of local insurance
  • Managing import licensing procedures
  • Translating and/or supporting translation of regulatory documentation
  • Delivering training and capacity-building initiatives for regulatory compliance

Why Their Work Matters

In clinical research, time and trust are everything. A well-executed regulatory strategy minimises delays, preserves data integrity, and builds confidence among regulatory bodies, sponsors, investigators, and participants.

At Pharmalys, we combine our extensive local knowledge with international standards to help our partners navigate regulatory complexity across Africa with clarity and confidence.

Want to learn more or work with our team?

Contact us at regulatory@pharmalys.com to explore how we can support your project.

Digital twins in clinical trials: opportunities and challenges

Digital twins in clinical trials: opportunities and challenges

A Digital Twin (DT) is a virtual representation of a physical entity, such as a patient or system, designed to simulate real world processes with precision. It enables the generation of a complete and realistic clinical patient trajectory, including modelling patient...

The second Pharmalys Voice meeting, June 2026

The second Pharmalys Voice meeting, June 2026

On 25 June 2026, Pharmalys colleagues came together virtually for the second Pharmalys Voice meeting of the year.  The meeting welcomed 35 participants across four continents, providing an opportunity to connect, exchange knowledge and celebrate the expertise...

Pharmalys at TCIS Africa Conference 2026, Pretoria, South Africa

Pharmalys at TCIS Africa Conference 2026, Pretoria, South Africa

Pharmalys assigned Jeanette, GCLP Team Lead, as the official Pharmalys representative the TCIS Africa Conference, held in Pretoria, South Africa, on 4–5 May 2026. The conference brought together a diverse and highly engaged community of professionals working across...

Pharmalys completes another successful GCLP audit in Romania

Pharmalys completes another successful GCLP audit in Romania

Pharmalys is pleased to announce the successful completion of another Good Clinical Laboratory Practice (GCLP) audit, conducted on 4-5 June 2026 at Medicover Integrated Clinical Services and its affiliated laboratory diagnostic services provider, Synevo Romania. The...